{"title":"Assist-Devices bei terminaler Herzinsuffizienz","authors":"S. Rojas, H. Fox, J. Gummert","doi":"10.1055/a-1081-6644","DOIUrl":"https://doi.org/10.1055/a-1081-6644","url":null,"abstract":"Rojas S e Die terminale Herzinsuffizienz stellt eine der Haupttodesursachen in Deutschland dar. Als einzige kurative Therapieoption ist die Herztransplantation weiterhin der Goldstandard. Jedoch übertrifft die Anzahl der Patienten mit terminaler Herzinsuffizienz die Zahl der jährlich durchgeführten Transplantationen um ein Vielfaches. Herzunterstützungssysteme haben eine wachsende Bedeutung als Alternative oder Überbrückung zur Transplantation erlangt.","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133842431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Herzstillstand im Krankenhaus: Gibt es Prognosefaktoren?","authors":"","doi":"10.1055/a-1292-7780","DOIUrl":"https://doi.org/10.1055/a-1292-7780","url":null,"abstract":"","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"78 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127132898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"ASS in der Primär- und Sekundärprävention kardiovaskulärer Erkrankungen","authors":"A. Hach, Reinhard J Sauter, H. Langer","doi":"10.1055/a-0917-8604","DOIUrl":"https://doi.org/10.1055/a-0917-8604","url":null,"abstract":"Das bereits im Jahr 1899 durch die Bayer AG patentierte Medikament Aspirin wird seit nunmehr knapp 120 Jahren erfolgreich in der Medizin eingesetzt [2]. ASS wird pharmakologisch der Gruppe der nicht steroidalen Antirheumatika zugeordnet. Es wirkt antipyretisch, antiinflammatorisch, analgetisch sowie antithrombotisch als Thrombozytenaggregationshemmer. Abhängig von der Indikationsstellung kann es sowohl peroral (p. o.) als auch intravenös (i. v.) verabreicht werden [3].","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"165 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116124375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Linksventrikuläre Non-Compaction-Kardiomyopathie","authors":"N. Verheyen, H. Juch, K. Ablasser","doi":"10.1055/a-1057-0680","DOIUrl":"https://doi.org/10.1055/a-1057-0680","url":null,"abstract":"","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126663415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Weniger Natrium ist besser – das gilt für alle!","authors":"","doi":"10.1055/a-1225-5846","DOIUrl":"https://doi.org/10.1055/a-1225-5846","url":null,"abstract":"Gut belegt ist, dass eine Reduktion der Natriumaufnahme über die Nahrung den Blutdruck bei Hypertonie senkt. Dissens herrscht allerdings darüber, ob eine solche Reduktion auch bei Menschen ohne Hypertonie günstig ist. Eine Metaanalyse untersuchte über die verschiedenen Populationen hinweg, ob es eine Dosisabhängigkeit zwischen der Reduktion der Natriumaufnahme mit der Nahrung und der Blutdruckveränderung gibt.","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131867174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Bridging unter Antikoagulation und Thrombozytenaggregationshemmung","authors":"E. Altiok, M. Almalla","doi":"10.1055/a-0886-2551","DOIUrl":"https://doi.org/10.1055/a-0886-2551","url":null,"abstract":"When bridging anticoagulation, the risk of bleeding - compared to the thromboembolic risk - is often underestimated. Bridging is only indicated in case of high (and possibly moderate) thromboembolic risk. When bridging patients with indication for dual antiplatelet therapy, an interdisciplinary case discussion should take place to assess the risk.","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133607788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Colchicin reduziert Risiko kardiovaskulärer Ereignisse nach Myokardinfarkt","authors":"","doi":"10.1055/a-1225-5820","DOIUrl":"https://doi.org/10.1055/a-1225-5820","url":null,"abstract":"Bei der Atherosklerose und ihren Komplikationen scheinen entzündliche Vorgänge eine Rolle zu spielen. Als potente antiinflammatorische Substanz wird Colchicin bei der Behandlung von Gicht und Perikarditis eingesetzt. Die Arbeitsgruppe berichtet über die Ergebnisse der COLCOT-Studie (Colchicine Cardiovascular Outcomes Trial), in der die Auswirkungen einer Niedrigdosistherapie mit Colchicin nach Myokardinfarkt untersucht wurden.","PeriodicalId":438592,"journal":{"name":"Kardiologie up2date","volume":"27 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114924270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
求助内容：
应助结果提醒方式：